Healthcare Global Enterprises LtdQ3 FY25Healthcare Services

Healthcare Global Enterprises Ltd

Q3 FY25 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 1

Fundraise

Yes

Order

N/A

Capex

Yes

3 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→Overall revenue growth expected to outpace industry, sustaining over 15% per annum.
→Average realization improvement targeted at 4% to 5% annually.
→Inpatient volume growth anticipated at 9% to 10% in near to midterm.
→Incremental revenue growth split: 70%-75% from existing centres, 10%-15% from brownfield expansion, and 8%-10% from greenfield projects.
→Existing network has significant growth potential through capacity expansion, addition of clinical teams, specialty mix enhancement, and technology upgrades.
→Medium-term goal to realize Rs.4,000 crore revenue potential over 4-5 years from current Rs.2,200 crore at existing price points and optimized utilization.
→Network growth driven by deepening clinical presence, expanding clinical domains, improving payor mix, strengthening brand, and scaling international business.
→New markets and acquisitions to add approximately 1,000 beds and 10 additional LINACs.

Margin guidance

Category 1

→Revenue growth expected at 15%+ CAGR over medium to long term, outpacing industry growth.
→EBITDA expected to grow faster than historical CAGR of 18%, supported by operational efficiencies, improved payor mix, and network optimization.
→Mature centers delivering EBITDA margins of 25% pre-corporate cost and ROCE around 27%; company-wide EBITDA margin expected to improve to 21%-22% in near term and higher in the long term.
→Incremental revenue largely from existing centers (70%-75%) with expansion via brownfield and greenfield projects adding about 1,000 beds and 10 LINACs.
→ROCE expected to be sustainably 20%+ over next five years as more centers mature and profitability improves.
→Capex of Rs.600-700 crore planned over 2-3 years, funded mainly through internal accruals to maintain net debt/EBITDA ratio between 2-2.5x.

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Healthcare Global Enterprises Ltd and 1,400+ other companies.

Fundraise plans

Yes

→The company has conserved capital over the last five years, reducing net debt to EBITDA ratio from 6.2x in FY2020 to about 2.3x in FY2025, showing focus on deleveraging.
→Current net debt to EBITDA ratio is comfortable at around 2.5x, with prudent leverage management.
→Capex of Rs.600-700 crore planned over the next 2-3 years; funding primarily to come from internal accruals and available borrowing headroom.
→The company is evaluating its equity and debt ratio and will take appropriate calls on raising equity or debt at the right time.
→For greenfield expansion, internal accruals will be the primary source of capital.
→No specific or immediate fundraising announced; future equity or debt raises will be considered as per strategic need.

Order book

The provided transcript and content from the Healthcare Global Enterprises Limited earnings call do not mention any details regarding a current or expected order book or pending orders. The discussion primarily revolves around: - Capacity expansion plans (adding 1,000 beds with ~700 beds via brownfield expansion and 200-400 beds via greenfield in select cities). - Capital expenditure plans (Rs.500-600 crore for expansion over next 2-3 years). - Focus on revenue growth, payor mix optimization, and margin improvement over 3-5 years. - Operational metrics, clinical strategy, and network maturity timelines. - No specific information on current or expected order book or pending orders is disclosed in the document.

Capex plans

Yes

→Next 2-3 years planned capex: Rs. 600-700 crore
→ - Rs. 300 crore dedicated to maintenance capex
→ - Remaining for upgrading infrastructure, increasing existing capacity, and brownfield expansion
→Brownfield expansion to add around 700 beds in markets like Ahmedabad, Vizag, Baroda, Cuttack
→Greenfield expansion planned in 10-12 new cities (e.g., Pune, Surat, Varanasi, Kanpur), adding 200-400 beds
→Greenfield projects largely funded through internal accruals, maintaining net debt to EBITDA ratio of 2-2.5x
→Each new centre's capex approximately Rs. 100 crore depending on market specifics
→Focus on cautious, disciplined capital allocation with emphasis on improving existing network efficiency and expanding through targeted market entry

How does Healthcare Global Enterprises Ltd rank vs peers in Healthcare Services?

Pro feature

1Healthcare Global Enterprises Ltd

Rev 3Mar 1

See full Healthcare Services sector rankings

Unlock with Pro

Want more stocks like Healthcare Global Enterprises Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio